Terms: = Skin cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406
361 results:
1. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract] [Full Text] [Related]
2. Association between Parkinson's Disease and cancer: New Findings and Possible Mediators.
Surguchov A; Surguchev AA
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612708
[TBL] [Abstract] [Full Text] [Related]
3. The Pediatric and Young Adult Choroidal and Ciliary Body Melanoma Genetic Study, A Survey by the European Ophthalmic Oncology Group.
van Poppelen NM; Cassoux N; Turunen JA; Naus NC; Verdijk RM; Vaarwater J; Cohen V; Papastefanou VP; Kiratli H; Saakyan SV; Tsygankov AY; Rospond-Kubiak I; Mudhar HS; Salvi SM; Kiilgaard JF; Heegaard S; Moulin AP; Saornil MA; Garciá-Alvarez C; Fili M; Eide NA; Meyer P; Kivelä TT; de Klein A; Kilic E; Al-Jamal RT
Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):12. PubMed ID: 38573618
[TBL] [Abstract] [Full Text] [Related]
4. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
5. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Value of bap1 Protein Expression in Uveal Melanoma.
Kennedy S; Owens S; Ivers L; Hegarty C; O'Neill V; Berenguer-Pina JJ; Horgan N; Crown J; Walsh N
Am J Surg Pathol; 2024 Mar; 48(3):329-336. PubMed ID: 38238977
[TBL] [Abstract] [Full Text] [Related]
7. Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.
Neo SY; Oliveira MMS; Tong L; Chen Y; Chen Z; Cismas S; Burduli N; Malmerfelt A; Teo JKH; Lam KP; Alici E; Girnita L; Wagner AK; Westerberg LS; Lundqvist A
J Exp Clin Cancer Res; 2024 Jan; 43(1):13. PubMed ID: 38191418
[TBL] [Abstract] [Full Text] [Related]
8. Uveal melanoma modeling in mice and zebrafish.
van den Bosch QCC; de Klein A; Verdijk RM; Kiliç E; Brosens E;
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189055. PubMed ID: 38104908
[TBL] [Abstract] [Full Text] [Related]
9. Combined Inhibition of EZH2 and FGFR is Synergistic in bap1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
[TBL] [Abstract] [Full Text] [Related]
11. Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis.
Reggiani F; Ambrosio M; Croce M; Tanda ET; Spagnolo F; Raposio E; Petito M; El Rashed Z; Forlani A; Pfeffer U; Amaro AA
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958591
[TBL] [Abstract] [Full Text] [Related]
12. Functional assay for assessment of pathogenicity of bap1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract] [Full Text] [Related]
13. Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
Lim JZ; Crawford AZ; McGhee CNJ
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
[TBL] [Abstract] [Full Text] [Related]
14. Pan-cancer analysis of the prognostic significance of
Dong H; Zhou S; Chen X; Deng X; Fang A
Expert Rev Clin Immunol; 2024 Feb; 20(2):225-236. PubMed ID: 37882761
[TBL] [Abstract] [Full Text] [Related]
15. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P
Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710
[TBL] [Abstract] [Full Text] [Related]
16. Spitz tumor with RAF1 fusion: A report of 3 cases.
Donati M; Nosek D; Olivares S; Lemahieu J; Loontiens S; Mansour B; Gerami P; Kazakov DV
Ann Diagn Pathol; 2023 Dec; 67():152215. PubMed ID: 37856952
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
18. bap1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
Zhang C; Wu S
Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185
[TBL] [Abstract] [Full Text] [Related]
19. Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.
Gentien D; Saberi-Ansari E; Servant N; Jolly A; de la Grange P; Némati F; Liot G; Saule S; Teissandier A; Bourc'his D; Girard E; Wong J; Masliah-Planchon J; Narmanli E; Liu Y; Torun E; Goulancourt R; Rodrigues M; Gaudé LV; Reyes C; Bazire M; Chenegros T; Henry E; Rapinat A; Bohec M; Baulande S; M'kacher R; Jeandidier E; Nicolas A; Ciriello G; Margueron R; Decaudin D; Cassoux N; Piperno-Neumann S; Stern MH; Gibcus JH; Dekker J; Heard E; Roman-Roman S; Waterfall JJ
Cell Rep; 2023 Sep; 42(9):113132. PubMed ID: 37708024
[TBL] [Abstract] [Full Text] [Related]
20. High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium.
Pellegrini C; Cardelli L; Ghiorzo P; Pastorino L; Potrony M; García-Casado Z; Elefanti L; Stefanaki I; Mastrangelo M; Necozione S; Aguilera P; Rodríguez-Hernández A; Di Nardo L; Rocco T; Del Regno L; Badenas C; Carrera C; Malvehy J; Requena C; Bañuls J; Stratigos AJ; Peris K; Menin C; Calista D; Nagore E; Puig S; Landi MT; Fargnoli MC
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2498-2508. PubMed ID: 37611275
[TBL] [Abstract] [Full Text] [Related]
[Next]
